— Know what they know.
Not Investment Advice

WST NYSE

West Pharmaceutical Services, Inc.
1W: +2.9% 1M: +6.6% 3M: +17.3% YTD: +43.0% 1Y: +28.6% 3Y: +7.6% 5Y: -2.3%
$398.20
+3.47 (+0.88%)
After Hours: $395.39 (-2.81, -0.71%)
Weekly Expected Move ±2.9%
$370 $381 $392 $403 $415
NYSE · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Buy · Power 71 · $27.8B mcap · 70M float · 0.940% daily turnover · Short 52% of daily vol
Credit Risk of going bust: lower than 93% of companies Debt: 1.1% of company value Bonds: none of note held by US funds details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $0.34 (down 99.9%), West Pharmaceutical Services, Inc. would be worth roughly what it owes.
Total debt $312.1M against a stock market value of $27.78B.
Distance to default 16.41 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $166.5M (short-term plus half of long-term), stock volatility 31.4%; Altman Z 18.65. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

📊 Key Metrics

TTM
$3B
Revenue
+12.4% YoY
$565M
Net Income
+15.8% YoY
$437M
Free Cash Flow
+27.0% YoY
37.7%
Gross Margin
20.5%
Op. Margin
17.7%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE19.1%
ROA14.1%
ROIC19.0%

Valuation

P/E50.5
P/B9.4
EV/EBITDA29.3

Leverage

Debt/Equity0.10
Current Ratio2.82
Interest Cov.6896.0x

Quality Scores

Piotroski F9/9
Altman Z17.45
Beneish M-3.79

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms